58 lines
4.2 KiB
Plaintext
58 lines
4.2 KiB
Plaintext
|
||
1. Westmorland MG, Williams RM, Amick BC III, Shannon H, Rasheed F. Disability management practices in Ontario workplaces: employees' perceptions. Disabil Rehabil. 2005;27:825-35.
|
||
https://doi.org/10.1080/09638280400020631
|
||
|
||
2. Solstad Vedeler J, Schreuer N. Policy in action: stories on the workplace accommodation process. J Disabil Policy Stud. 2011;22:95-105.
|
||
https://doi.org/10.1177/1044207310395942
|
||
|
||
3. Medin J, Barajas J, Ekberg K. Stroke patients' experiences of return to work. Disabil Rehabil. 2006;28:1051-60.
|
||
https://doi.org/10.1080/09638280500494819
|
||
|
||
4. Lock S, Jordan L, Bryan K, Maxim J. Work after stroke: focusing on barriers and enablers. Disabil Soc. 2005;20:33-47.
|
||
https://doi.org/10.1080/0968759042000283629
|
||
|
||
5. Gold PB, Oire SN, Fabian ES, Wewiorski NJ. Negotiating reasonable workplace accommodations: perspectives of employers, employees with disabilities, and rehabilitation service providers. J Vocat Rehab. 2012;37:25-37.
|
||
https://doi.org/10.3233/JVR-2012-0597
|
||
|
||
6. Dyck I, Jongbloed L. Women with multiple sclerosis and employment issues: a focus on social and institutional environments. Can J Occup Ther. 2000;67:337-46.
|
||
https://doi.org/10.1177/000841740006700506
|
||
|
||
7. de Jonge DM, Rodger SA. Consumer-identified barriers and strategies for optimizing technology use in the workplace. Disabil Rehabil: Assist Technol. 2006;1:79-88.
|
||
https://doi.org/10.1080/09638280500167324
|
||
|
||
8. Crooks VA. Women's experiences of developing musculoskeletal diseases: employment challenges and policy recommendations. Disabil Rehabil. 2007;29:1107-16.
|
||
https://doi.org/10.1080/09638280600948193
|
||
|
||
9. Yelin E, Sonneborn D, Trupin L. The prevalence and impact of accommodations on the employment of persons 51-61 years of age with musculoskeletal conditions. Arthritis Care Res. 2000;13:168-76.
|
||
https://doi.org/10.1002/1529-0131(200006)13:3<168::AID-ANR6>3.0.CO;2-R
|
||
|
||
10. Radford K, Phillips J, Drummond A, Sach T, Walker M, Tyerman A, Haboubi N, Jones T. Return to work after traumatic brain injury: cohort comparison and economic evaluation. Brain Inj. 2013;27:507-20.
|
||
https://doi.org/10.3109/02699052.2013.766929
|
||
|
||
11. Allaire SH, Li W, LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation. Arthritis Rheum. 2003;48:3212-8.
|
||
https://doi.org/10.1002/art.11256
|
||
|
||
|
||
Do not use your browser's 'BACK' button.
|
||
Use the 'RESET' button to submit more references.
|
||
|
||
We now provide space to match 1,000 references per submission
|
||
|
||
To learn about other services and interfaces see our MetaData Delivery page.
|
||
|
||
Please contact us if you have any questions.
|
||
|
||
Tips:
|
||
There should be no line breaks within an individual reference.
|
||
When submitting multiple references they must be in alphabetical order or presented as a numbered list.
|
||
To check the accuracy of a reference, click on the link that is returned with the reference.
|
||
You may use any reference style, although it works best if references are formatted in a consistent and standard style. Just cut and paste this example list to try it out:
|
||
1. Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Resp J 23: 146–158.
|
||
2. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Investig 109: 571–577.
|
||
3. Antunes MB, Cohen NA (2007) Mucociliary clearance - a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 7: 5–10.
|
||
4. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, et al. (1989) Identification of the Cystic-Fibrosis Gene - Cloning and Characterization of Complementary-Dna. Science 245: 1066–1072.
|
||
5. Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, et al. (1989) Identification of the Cystic-Fibrosis Gene - Chromosome Walking and Jumping. Science 245: 1059–1065.
|
||
6. Bobadilla JL, Macek M, Fine JP, Farrell PM (2002) Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening. Human Mutation 19: 575–606.
|
||
7. Qu BH, Thomas PJ (1996) Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway - Effects of the Delta F508 mutation on the thermodynamic stability and folding yield of NBD1. J Biol Chem 271: 7261–7264.
|
||
|